ZUMA-2
CAR T-Cell Therapy Extends Survival in Relapsed/Refractory Mantle Cell Lymphoma
ORLANDO, FLA.—In patients with relapsed or refractory mantle cell lymphoma and few remaining treatment ...
FEBRUARY 25, 2020

Load more